DarioHealth (DRIO) Insider Purchase: Steven Nelson Adds 40,000 Shares

Rhea-AI Filing Summary

Steven Nelson, President and CCO of DarioHealth Corp. (DRIO), reported an open-market purchase of common stock on 08/27/2025. The Form 4 shows a purchase of 40,000 shares at $0.53 per share, bringing his reported beneficial ownership to 95,000 shares. The filing identifies Nelson as a director and officer and is signed by him on 08/27/2025.

Positive

• Insider purchase disclosed: 40,000 common shares acquired at $0.53, increasing reported beneficial ownership to 95,000 shares

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider purchased 40,000 shares at $0.53, modestly increasing reported holdings to 95,000 shares.

The transaction is a routine Section 16 filing documenting an insider open-market purchase. At $0.53 per share for 40,000 shares, the reported cash outlay is $21,200. This increases the insider's direct beneficial ownership to 95,000 shares. The disclosure is timely and complete for the single non-derivative transaction reported.

Corporate Governance Expert

TL;DR: Filing reflects standard insider disclosure with no governance red flags.

The Form 4 identifies the reporting person as President, CCO and director and shows a straightforward purchase (code P). The filing is signed and dated, meeting disclosure requirements. No dispositions, derivative transactions, or indications of 10b5-1 plan usage are reported in this document.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nelson Steven Charles

(Last) (First) (Middle)

322 W 57TH ST, #33B

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DarioHealth Corp. [ DRIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CCO

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		P		40,000	A	$0.53	95,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Steven Nelson	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Steven Nelson report on the Form 4 for DRIO?

The Form 4 reports a purchase of 40,000 common shares at $0.53 per share on 08/27/2025.

How many shares does Steven Nelson beneficially own after the reported transaction?

Following the reported purchase, Steven Nelson beneficially owns 95,000 shares according to the Form 4.

What is Steven Nelson's role at DarioHealth Corp. (DRIO)?

The Form 4 lists Steven Nelson as a director and as an officer with the titles President and CCO.

Was the Form 4 properly signed and dated?

Yes. The filing includes a signature by /s/ Steven Nelson dated 08/27/2025.

Does the Form 4 report any derivative transactions or dispositions?

No. The Form 4 reports only a non-derivative acquisition (purchase) and no derivative transactions or dispositions.